The Val66Met polymorphism of the brain-derived neurotrophic factor gene is not associated with risk for schizophrenia and tardive dyskinesia in Han Chinese population

Schizophrenia Research

Volumn 120, Issue 1-3, 2010, Pages 240-242

  Wang, Yu ^a   Wang, Jiang Dong ^b   Wu, Hao Ran ^c   Zhang, Ben Shu ^a   Fang, Hui ^b   Ma, Qi Min ^c   Liu, Hong ^a   Chen, Da Chun ^d   Xiu, Mei Hong ^d   Hail, Colin N ^e   Kosten, Thomas R ^e   Zhang, Xiang Yang ^d,e  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Rongjun Hospital of Hebei Province   (China)

^d BEIJING HUILONGGUAN HOSPITAL   (China)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; NEUROLEPTIC AGENT; VALINE;

ADULT; ALLELE; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; TARDIVE DYSKINESIA; AKATHISIA; ASIAN CONTINENTAL ANCESTRY GROUP; CHI SQUARE DISTRIBUTION; ETHNOLOGY; GENETICS; MIDDLE AGED;

ADULT; AKATHISIA, DRUG-INDUCED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; METHIONINE; MIDDLE AGED; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; VALINE;

EID: 77954143925     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.03.020     Document Type: Letter

References (11)

1. Bakker P.R., van Harten P.N., van Os J. Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions. Mol. Psychiatry 2008, 13(5):544-556.
2. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112(2):257-269.
3. Kang S.G., Choi J.E., An H., Lim S.W., Lee H.J., Han C., Kim Y.K., Kim S.H., Cho S.N., Lee M.S., Joe S.H., Jung I.K., Kim L. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(6):1545-1548.
4. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 1996, 19:289-317.
5. Liou Y.J., Liao D.L., Chen J.Y., Wang Y.C., Lin C.C., Bai Y.M., Yu S.C., Lin M.W., Lai I.C. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Neuromolecular Med. 2004, 5(3):243-251.
6. Lohr J.B., Kuczenski R., Niculescu A.B. Oxidative mechanisms and tardive dyskinesia. CNS Drugs 2003, 17:47-62.
7. Park S.W., Lee J.G., Kong B.G., Lee S.J., Lee C.H., Kim J.I., Kim Y.H. Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia. Psychiatry Clin. Neurosci. 2009, 63(4):433-439.
8. Schooler N.R., Kane J.M. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry 1982, 39(4):486-487.
9. Tan Y.L., Zhou D.F., Zhang X.Y. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr. Res. 2005, 74(2-3):263-270.
10. Zai C.C., Tiwari A.K., De Luca V., Müller D.J., Bulgin N., Hwang R., Zai G.C., King N., Voineskos A.N., Meltzer H.Y., Lieberman J.A., Potkin S.G., Remington G., Kennedy J.L. Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia. Eur. Neuropsychopharmacol. 2009, 19(5):317-328.
11. Zhang X.Y., Zhou D.F., Wu G.Y., Cao L.Y., Tan Y.L., Haile C.N., Li J., Lu L., Kosten T.A., Kosten T.R. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Neuropsychopharmacology 2007, 33(9):2200-2205.